Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)

SHA:603896 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	697.43	853.64	1,504	1,525	677.98	669.25
Trading Asset Securities	381.8	344.69	-	30	130	50
Cash & Short-Term Investments	1,079	1,198	1,504	1,555	807.98	719.25
Cash Growth	-7.28%	-20.32%	-3.26%	92.42%	12.34%	77.98%
Accounts Receivable	81.61	119.31	113.06	137.68	117.25	81.79
Other Receivables	4.71	2.86	3.25	2.51	3.36	2.53
Receivables	86.32	122.16	116.32	140.19	120.61	84.33
Inventory	236.35	179.55	157.83	147.76	99.06	99.38
Other Current Assets	34.8	22.3	28.73	19.35	17.64	19.85
Total Current Assets	1,437	1,522	1,807	1,862	1,045	922.8
Property, Plant & Equipment	1,052	914.24	682.32	601.14	515.91	373.66
Long-Term Investments	95.82	94.85	65.71	63.8	66.46	82.12
Other Intangible Assets	352.98	352.86	310.98	78.16	82.98	78.58
Long-Term Deferred Tax Assets	-	-	-	-	0.37	1.04
Long-Term Deferred Charges	44.58	68.65	79.78	53.13	39.93	27.73
Other Long-Term Assets	172.8	178.24	228.71	197.94	211.51	213.65
Total Assets	3,155	3,131	3,174	2,856	1,962	1,700
Accounts Payable	146.85	132.1	132.71	103.98	107.94	56.61
Accrued Expenses	25.03	36.88	40.28	71.15	54.03	54.25
Short-Term Debt	155.6	187.4	372.16	272.97	-	-
Current Portion of Leases	14.13	15.4	12.08	4.87	5.63	-
Current Income Taxes Payable	8.62	-	0.02	0.24	0.02	1.42
Current Unearned Revenue	15.18	11.64	10.1	9.03	9.61	7.72
Other Current Liabilities	10.98	6.75	17.79	15.53	22.05	44.7
Total Current Liabilities	376.4	390.18	585.15	477.77	199.28	164.69
Long-Term Debt	379.96	361.01	340.19	412.59	87.6	188.13
Long-Term Leases	22.81	22.76	23.97	15.97	13.33	-
Long-Term Unearned Revenue	54.12	54.86	49.98	41.3	38.23	16.12
Long-Term Deferred Tax Liabilities	8.6	8.35	3.78	3.04	3.98	4.34
Total Liabilities	841.89	837.17	1,003	950.67	342.41	373.28
Common Stock	198.24	198.24	201.83	197.2	152.5	148.01
Additional Paid-In Capital	818.22	804.52	966.03	856.25	900.22	768.82
Retained Earnings	1,176	1,173	1,076	908.45	690.99	536.05
Treasury Stock	-	-	-165.11	-165.11	-165.11	-194.12
Comprehensive Income & Other	119.1	118.15	92.83	108.73	41.06	67.56
Total Common Equity	2,312	2,294	2,171	1,906	1,620	1,326
Minority Interest	0.98	-	-	-	0.38	-
Shareholders' Equity	2,313	2,294	2,171	1,906	1,620	1,326
Total Liabilities & Equity	3,155	3,131	3,174	2,856	1,962	1,700
Total Debt	572.5	586.57	748.4	706.41	106.56	188.13
Net Cash (Debt)	506.73	611.76	755.56	848.31	701.42	531.12
Net Cash Growth	-11.32%	-19.03%	-10.93%	20.94%	32.06%	34.76%
Net Cash Per Share	2.57	3.08	3.86	4.37	3.67	2.88
Filing Date Shares Outstanding	198.24	198.24	198.24	197.2	198.25	192.41
Total Common Shares Outstanding	198.24	198.24	198.24	197.2	198.25	192.41
Working Capital	1,060	1,132	1,222	1,384	846.02	758.11
Book Value Per Share	11.66	11.57	10.95	9.66	8.17	6.89
Tangible Book Value	1,959	1,941	1,860	1,827	1,537	1,248
Tangible Book Value Per Share	9.88	9.79	9.38	9.27	7.75	6.48
Buildings	-	350.9	308.29	357.46	355.62	194.11
Machinery	-	250.68	241.18	198.58	145.46	121.26
Construction In Progress	-	501.72	280.21	169.63	115.34	155.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.